138 related articles for article (PubMed ID: 1319460)
1. Temafloxacin vs ciprofloxacin for UTI.
Hornstein LE
J Fam Pract; 1992 Jul; 35(1):14; author reply 18. PubMed ID: 1319460
[No Abstract] [Full Text] [Related]
2. Temafloxacin vs ciprofloxacin for UTI.
Ganiats TG; Norcross WA
J Fam Pract; 1992 Jul; 35(1):14, 16, 18. PubMed ID: 1319461
[No Abstract] [Full Text] [Related]
3. Comparison of three-day temafloxacin with seven-day ciprofloxacin treatment of urinary tract infections in women.
Stein GE; Philip E
J Fam Pract; 1992 Feb; 34(2):180-4. PubMed ID: 1310715
[TBL] [Abstract][Full Text] [Related]
4. [Maxaquin and ciprofloxacin in the treatment of complicated and recurrent urinary infections in adults].
Savitskaia KI; Trapeznikova MF; Nekhorosheva AG; Solodilova OE; Nasonov VN; Dutov VV; Kalinin VN; Shanina AG; Rusanova EV
Klin Med (Mosk); 1994; 72(2):38-42. PubMed ID: 8015241
[TBL] [Abstract][Full Text] [Related]
5. [Urinary tract infections: risk factors and therapeutic trends].
Margariti PA; Astorri AL; Mastromarino C
Recenti Prog Med; 1997 Feb; 88(2):65-8. PubMed ID: 9148368
[TBL] [Abstract][Full Text] [Related]
6. The expanding role of fluoroquinolones.
Schaeffer AJ
Dis Mon; 2003 Feb; 49(2):129-47. PubMed ID: 12601342
[TBL] [Abstract][Full Text] [Related]
7. Treatment of uncomplicated urinary tract infections with temafloxacin.
Iravani A
Am J Med; 1991 Dec; 91(6A):124S-128S. PubMed ID: 1662882
[TBL] [Abstract][Full Text] [Related]
8. Prophylactic antibiotics in renal transplantation.
Melchor JL; Gracida C
Transplant Proc; 1996 Dec; 28(6):3305. PubMed ID: 8962283
[No Abstract] [Full Text] [Related]
9. A trial comparing low-dose, short-course ciprofloxacin and standard 7 day therapy with co-trimoxazole or nitrofurantoin in the treatment of uncomplicated urinary tract infection.
Iravani A; Klimberg I; Briefer C; Munera C; Kowalsky SF; Echols RM
J Antimicrob Chemother; 1999 Mar; 43 Suppl A():67-75. PubMed ID: 10225575
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic efficacy of ofloxacin, ciprofloxacin and NY-198 in experimentally infected normal and alloxan-induced diabetic mice.
Obana Y; Nishino T
Drugs Exp Clin Res; 1988; 14(5):327-31. PubMed ID: 3219995
[TBL] [Abstract][Full Text] [Related]
11. Two new fluoroquinolones.
Med Lett Drugs Ther; 1992 Jun; 34(872):58-60. PubMed ID: 1317502
[No Abstract] [Full Text] [Related]
12. Therapeutic effect of the quinolone prodrug prulifloxacin against experimental urinary tract infections in mice.
Tomii Y; Ozaki M; Matsuda M; Honmura T; Nishimura I; Yamaguchi R; Adachi T; Okawa Y; Nishino T
Arzneimittelforschung; 1996 Dec; 46(12):1169-73. PubMed ID: 9006794
[TBL] [Abstract][Full Text] [Related]
13. Anti-Mycobacterium leprae activity of several quinolones studied in the mouse.
Pattyn SR
Int J Lepr Other Mycobact Dis; 1991 Dec; 59(4):613-7. PubMed ID: 1666402
[TBL] [Abstract][Full Text] [Related]
14. Comparative, double-blind, prospective, multicenter trial of temafloxacin versus trimethoprim-sulfamethoxazole in uncomplicated urinary tract infections in women.
Iravani A
Antimicrob Agents Chemother; 1991 Sep; 35(9):1777-81. PubMed ID: 1952847
[TBL] [Abstract][Full Text] [Related]
15. Extended-release ciprofloxacin (Cipro XR) for treatment of urinary tract infections.
Talan DA; Naber KG; Palou J; Elkharrat D
Int J Antimicrob Agents; 2004 Mar; 23 Suppl 1():S54-66. PubMed ID: 15037329
[TBL] [Abstract][Full Text] [Related]
16. Lomefloxacin versus ciprofloxacin in the treatment of complicated urinary tract infections: a multicenter study.
Pisani E; Bartoletti R; Trinchieri A; Rizzo M
J Chemother; 1996 Jun; 8(3):210-3. PubMed ID: 8808718
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of temafloxacin versus ciprofloxacin in lower respiratory tract infections: a randomized, double-blind trial.
Lindsay G; Scorer HJ; Carnegie CM
J Antimicrob Chemother; 1992 Jul; 30(1):89-100. PubMed ID: 1331020
[TBL] [Abstract][Full Text] [Related]
18. Trimethoprim-sulfamethoxazole compared with ciprofloxacin for the prevention of urinary tract infection in renal transplant recipients. A double-blind, randomized controlled trial.
Hibberd PL; Tolkoff-Rubin NE; Doran M; Delvecchio A; Cosimi AB; Delmonico FL; Auchincloss H; Rubin RH
Online J Curr Clin Trials; 1992 Aug; Doc No 15():[4083 words; 46 paragraphs]. PubMed ID: 1343609
[TBL] [Abstract][Full Text] [Related]
19. [The use of Maxaquin (lomefloxacin hydrochloride) in the treatment of nonspecific inflammatory diseases and in the prevention of surgical interventions in urology].
Derevianko II; Lopatkin NA; Khodyreva LA; Kondrat'eva EM
Urol Nefrol (Mosk); 1998; (5):14-8. PubMed ID: 9820038
[No Abstract] [Full Text] [Related]
20. Criteria for use of ofloxacin and lomefloxacin in adult inpatients and outpatients.
Spivey IM
Clin Pharm; 1993 Jun; 12(6):452-8. PubMed ID: 8403817
[No Abstract] [Full Text] [Related]
[Next] [New Search]
